See the DrugPatentWatch profile for cosentyx

Cosentyx (secukinumab) is a medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It is typically administered via subcutaneous injection [1].

For plaque psoriasis, the usual dosage is 300 mg (two 150 mg injections) at Week 0, Week 1, Week 2, and then 300 mg every 4 weeks [1]. Therefore, for plaque psoriasis, Cosentyx is typically injected once every 4 weeks, or monthly.

For psoriatic arthritis and ankylosing spondylitis, the recommended dosage is 150 mg at Week 0, Week 1, Week 2, and then 150 mg every 4 weeks [1]. Hence, for these conditions, Cosentyx is also typically injected once every 4 weeks, or monthly.

It's important to note that the dosage may vary depending on the patient's response to treatment and the specific condition being treated. Always consult with a healthcare provider for personalized medical advice.

Sources:
[1] DrugPatentWatch.com. (n.d.). Cosentyx (secukinumab) Dosage. Retrieved from https://www.drugpatentwatch.com/cosentyx-secukinumab-dosage/